Aemetis, Inc (AMTX)

Name: Aemetis, Inc (AMTX) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

SEC name AEMETIS, INC · CIK 0000738214 · Nasdaq · Industrial Organic Chemicals

Sector Manufacturing
Incorporated NV
Fiscal year ends Dec 31

For the year ended 2025-12-31, Aemetis, Inc reported revenue of $197.63M. Revenue fell 26.2% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $219.82M.

Key ratios (year ended 2025-12-31)

-0.4%

Gross margin

-18.8%

Operating margin

-39.0%

Net margin

-26.2%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-Q (quarterly report) · 2026-08-06

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	$219.82M	$197.63M	$267.64M	$186.72M	$256.51M	$211.95M	$165.56M	$202.00M	$171.53M	$150.16M	$143.16M
Cost of Revenue	$206.23M	$208.75M	$268.22M	$184.70M	$262.05M	$204.01M	$154.53M	$189.30M	$166.12M	$146.78M	$131.56M
Gross Profit	$23.94M	-$768.0K	-$580.0K	$2.02M	-$5.54M	$7.94M	$11.03M	$12.70M	$5.41M	$3.38M	$11.60M
R&D Expense	n/a	n/a	n/a	$152.0K	$180.0K	$88.0K	$213.0K	$205.0K	$246.0K	$2.37M	$369.0K
Operating Income	-$11.55M	-$37.22M	-$40.42M	-$37.40M	-$34.40M	-$15.82M	-$6.07M	-$4.93M	-$10.93M	-$12.18M	-$781.0K
Depreciation & Amortization	n/a	$9.62M	$8.39M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA	n/a	-$27.59M	-$32.03M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Net Income	-$60.16M	-$77.00M	-$87.54M	-$46.42M	-$107.76M	-$47.15M	-$36.66M	-$39.48M	-$36.29M	-$31.77M	-$15.64M
EPS (Diluted)	n/a	-$1.28	-$1.91	-$1.22	-$3.12	-$1.54	-$1.74	-$1.75	-$1.63	-$1.53	-$0.79
Total Assets	$289.18M	$259.84M	$259.30M	$243.41M	$207.11M	$160.83M	$125.14M	$99.89M	$91.82M	$94.33M	$77.81M
Long-Term Debt	n/a	n/a	$338.06M	$294.72M	$246.24M	$189.70M	$230.07M	$179.69M	$157.82M	$138.16M	$100.31M
Shareholders' Equity	-$322.11M	-$306.83M	-$263.93M	-$216.98M	-$201.85M	-$120.24M	-$184.74M	-$154.37M	-$110.84M	-$78.39M	-$49.81M
Cash & Equivalents	$973.0K	$4.89M	$898.0K	$2.67M	$4.31M	$7.75M	$592.0K	$656.0K	$1.19M	$428.0K	$1.49M
Operating Cash Flow	-$3.60M	$3.26M	-$32.93M	$13.82M	-$22.87M	-$20.65M	$2.48M	-$2.03M	-$5.51M	-$8.69M	$371.0K
Capital Expenditures	$35.73M	$26.00M	$20.25M	$33.12M	$39.16M	$26.65M	$19.34M	$8.58M	$4.07M	$1.12M	$629.0K
Free Cash Flow	-$39.33M	-$22.74M	-$53.18M	-$19.29M	-$62.02M	-$47.30M	-$16.86M	-$10.61M	-$9.58M	-$9.80M	-$258.0K
Share Repurchases	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	$0
Shares Outstanding	72.05M	66.19M	51.14M	40.97M	35.87M	33.46M	n/a	n/a	n/a	n/a	n/a
Weighted Average Diluted Shares	n/a	59.98M	45.90M	38.06M	34.59M	30.68M	21.01M	20.47M	n/a	n/a	n/a
EPS (Basic)	n/a	-$1.28	-$1.91	-$1.22	-$3.12	-$1.54	-$1.74	-$1.75	-$1.63	-$1.53	-$0.79

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView